共 46 条
Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease
被引:32
作者:
Tsang, Shirley W. Y.
Pomakian, Justine
Marshall, Gad A.
Vinters, Harry V.
Cummings, Jeffrey L.
Chen, Christopher P. L. -H.
Wong, Peter T. -H.
Lai, Mitchell K. P.
机构:
[1] Singapore Gen Hosp, Dept Clin Res, Dementia Res Lab, Singapore 169608, Singapore
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[5] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore
关键词:
muscarinic receptors;
glutamate receptors;
protein kinase C;
Src kinase;
neocortex;
D O I:
10.1016/j.neurobiolaging.2006.06.001
中图分类号:
R592 [老年病学];
C [社会科学总论];
学科分类号:
03 ;
0303 ;
100203 ;
摘要:
There are few studies on the clinical and neurochemical correlates of postsynaptic cholinergic dysfunction in Alzheimer's disease (AD). We have previously found that attenuation of guanine nucleotide-binding (G-) protein coupling to muscarinic M-1 receptors in the neocortex was associated with dementia severity. The present study aims to study whether this loss of M-1/G-protein coupling is related to alterations in signaling kinases and NMDA receptors. Postmortem frontal cortices of 22 AD subjects and 12 elderly controls were obtained to measure M-1 receptors, M-1/G-protein coupling, NMDA receptors as well as protein kinase C (PKC and Src kinase activities. We found that the extent of M-1/G-protein coupling loss was correlated with reductions in PKC activity and NMDA receptor density. In contrast, Src kinase activity was neither altered nor associated with M-1/G-protein coupling. Given the well established roles of neuronal PKC signaling and NMDA receptor function in cognitive processes, our results lend further insight into the mechanisms by which postsynaptic cholinergic dysfunction may underlie the cognitive features of AD, and suggest alternative therapeutic targets to cholinergic replacement. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1381 / 1387
页数:7
相关论文